Clinical trial · Observational
Validity of Mediastinal Blood Pool SUV Ratio
Is Mediastinal Blood Pool SUV Ratio Valid in Identification of Malignancy in Comparison to Liver SUV Ratio?
NCT05258045CI-TRIAL-00056773unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
-Validity of blood pool SUV ratio in identification of malignancy in case of diseased liver.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Validity of Blood Pool SUV Ratio in Identification of Malignancy in Case of Diseased Liver | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| F18 FDG | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- SUV ratio of mediastinal blood pool to the lesion and SUV ratio of liver to lesion
- description
- Avidity of SUV of blood pool
- interventionNames
- Radiation: F18 FDG
Primary outcomes (1)
- measure
- -Validity of blood pool suv ratio in identification of malignancy in case of diseased liver.
- timeFrame
- One year
- description
- PET/CT is the functional imaging tool that can measure increased glucose metabolism in cancer tissues by using flourine 18 FDG which is FDA approved and used routinely in identification of malignant lesions , staging and restaging of many maligancy like lymphoma, breast cancer, lung cancer and cancer colon. In clinical routine, SUV is often used to determine the glucose metabolism in tumours by 18F-FDG PET/CT. And can be further normalised to SUVs in reference regions resulting in a SUV ratio (SUV ratio).in routine work SUV of the lesion is normalised to SUV of the liver , but this not used if the liver is diseased like as liver cirrhosis or liver metastases , so SUV ratio of lesion to mediastinal blood pool and SUV ratio of the lesion to liver will be measured in correlation to pathology to assess validity of SUV of mediastinal blood pool.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * This study will include cancer pt who did PET/CT scan who presented to nuclear medicine unit during the period from 2021 until the end of the study. Exclusion Criteria: * Severely ill patient * Pt with glucose level above 200
References
Publications (0)
Data not yet available
No reference posted for this study.